Diabetes Research and Clinical Practice 2011-08-01

DPP-IV inhibitor may affect spermatogenesis.

Hatsuki Hibi, Tadashi Ohori, Yoshiaki Yamada

Index: Diabetes Res. Clin. Pract. 93(2) , e74-5, (2011)

Full Text: HTML

Abstract

A 39-year-old physician was diagnosed retrograde ejaculation due to diabetes and treated with amoxapine. This treatment was effective; he could ejaculate. He began receiving DPP-IV inhibitor (Sitagliptin 50 mg, daily), in lieu of insulin injection. Unusual effect on semen quality was occurred following the administration of the drug.Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Related Compounds

Related Articles:

Inhibition of G protein-activated inwardly rectifying K+ channels by different classes of antidepressants.

2011-01-01

[PLoS ONE 6(12) , e28208, (2011)]

Investigation of the disposition of loxapine, amoxapine and their hydroxylated metabolites in different brain regions, CSF and plasma of rat by LC–MS/MS

2012-01-01

[J. Pharm. Biomed. Anal. 58 , 83-93, (2012)]

Validation of HPLC-MS/MS methods for analysis of loxapine, amoxapine, 7-OH-loxapine, 8-OH-loxapine and loxapine N-oxide in human plasma.

2010-12-01

[Bioanalysis 2(12) , 1989-2000, (2010)]

Potential repurposing of known drugs as potent bacterial β-glucuronidase inhibitors.

2012-08-01

[J. Biomol. Screen. 17(7) , 957-65, (2012)]

Amoxapine-associated acute respiratory distress.

2008-01-01

[Respirology 13(1) , 149-51, (2008)]

More Articles...